?>

Osiris Therapeutics wins contract for development of radiation treatment

by: Matthew Potter
January 4, 2008

Category: Department of Defense, development program, medicine, Osiris Therapuetics | RSS 2.0

The Department of Defense awarded Osiris Therapuetics a contract that might be worth $224 M dollars to utilize a stem-cell therapy drug to treat radiation caused gastrointestinal injuries. See CNNMoney.com story here. The initial funding of $4 M is to develop the treatment, with another $200 M possible if the DoD decides to purchase units. This is an example of how diverse DoD spending is. It is not just for bullets, beans, gas and soldiers.

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter

| Give a Comment | trackback

2 Comments

  1. Cleveland BioLabs Loses Out to Osiris For Radiation Treatment Contract | Defense Procurement News on January 4th, 2008 10:38 pm

    […] we reported earlier today, Osiris Therapeutics won a Department of Defense contract to develop a treatment for radiation […]

  2. Osiris defense contract makes company take off | Defense Procurement News on January 12th, 2008 6:25 am

    […] gastrointestinal system has really caused the company and its stock to take off. See previous posts here and here for more detail. The contract could be worth $225 M initially, and if the US Government […]

Leave a Reply

You must be logged in to post a comment.

    Like Us On Facebook

  • Search This Site

    Custom Search
  • Upcoming Events

  • FREE Business Downloads

  • Widget Area

    This is widget area, add your widget here from your widget on appereance on your admin panel

>